It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis.
Alberto MiglioreG GigliucciR J PetrellaRaveendhara R BannuruXavier ChevalierE MaheuR RamanGabriel Herrero-BeaumontN IsailovicM Matucci CerincPublished in: Therapeutics and clinical risk management (2019)
Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a "treat to target strategy" for KOA.